CORPORATE

CORPORATE
PROFILE

Company NameMetcela Inc.
FoundedMarch 9, 2016
Outline of BusinessResearch and development of fibroblast-based therapies for cardiac diseases

ACCESS

Kawasaki Headquarter

Life Innovation Center 3-25-22Tonomachi, Kawasaki-ku,Kawasaki-shi, Kanagawa 210-0821


iCONM Lab/Office

3-25-14Tonomachi,Kawasaki-ku,Kawasaki-shi, Kanagawa 210-0821

HISTORY

2014
Launched Project Metcela

2016.03
Incorporated Metcela Inc.

2016.06
Chosen for STS grant (JPY 70M) from NEDO

2017.03
Chosen for SCA grant (JPY 70M) from NEDO

2017.04
Initiated joint research with University of Tsukuba

2018.07
Chosen for Hashiwatashi grant from NEDO

2018.09
Raised $4.6 Million in Series A Financing Round

2018.12
Headquartered in Kawasaki City, Kanagawa Prefecture

2019.06
Selected for J-Startup 2019, a government-led initiative for supporting startups

2020.06
Signed a business partnership agreement with Japan Lifeline Co., Ltd.

2021.01
Secured $12.7 Million in Series B Financing Round

2021.07
Initiated Phase I clinical trial for chronic ischemic heart failure

2022.04
Acquired Japan Regenerative Medicine Co., Ltd.

2022.06
Mergered with Japan Regenerative Medicine Co., Ltd.

2022.06
Raised $14 Million in Series C Financing Round

2022.11
Chosen for CiCLE grant program from AMED